As of 2024-12-14, the Relative Valuation of Vaxcyte Inc (PCVX) is (109.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 87.72 USD, the upside of Vaxcyte Inc based on Relative Valuation is -224.9%.
The range of the Relative Valuation is (112.25) - (124.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 44.6x | 34.4x |
| Forward P/E multiples | 19.0x - 30.5x | 19.4x |
| Fair Price | (112.25) - (124.14) | (109.56) |
| Upside | -228.0% - -241.5% | -224.9% |
| Date | P/E |
| 2024-11-29 | -23.16 |
| 2024-11-27 | -23.07 |
| 2024-11-26 | -22.45 |
| 2024-11-25 | -22.51 |
| 2024-11-22 | -21.74 |
| 2024-11-21 | -21.70 |
| 2024-11-20 | -21.11 |
| 2024-11-19 | -21.38 |
| 2024-11-18 | -21.24 |
| 2024-11-15 | -21.32 |
| 2024-11-14 | -22.76 |
| 2024-11-13 | -23.73 |
| 2024-11-12 | -24.40 |
| 2024-11-11 | -25.45 |
| 2024-11-08 | -26.19 |
| 2024-11-07 | -25.22 |
| 2024-11-06 | -25.55 |
| 2024-11-05 | -26.41 |
| 2024-11-04 | -26.15 |
| 2024-11-01 | -26.34 |
| 2024-10-31 | -26.11 |
| 2024-10-30 | -26.05 |
| 2024-10-29 | -25.92 |
| 2024-10-28 | -27.70 |
| 2024-10-25 | -27.73 |
| 2024-10-24 | -27.58 |
| 2024-10-23 | -27.53 |
| 2024-10-22 | -27.66 |
| 2024-10-21 | -28.35 |
| 2024-10-18 | -28.36 |
| 2024-10-17 | -28.39 |
| 2024-10-16 | -28.95 |
| 2024-10-15 | -28.36 |
| 2024-10-14 | -27.77 |
| 2024-10-11 | -28.09 |
| 2024-10-10 | -27.40 |
| 2024-10-09 | -27.47 |
| 2024-10-08 | -27.44 |
| 2024-10-07 | -26.63 |
| 2024-10-04 | -27.32 |
| 2024-10-03 | -27.27 |
| 2024-10-02 | -28.05 |
| 2024-10-01 | -28.37 |
| 2024-09-30 | -28.06 |
| 2024-09-27 | -27.78 |
| 2024-09-26 | -27.36 |
| 2024-09-25 | -27.86 |
| 2024-09-24 | -28.39 |
| 2024-09-23 | -27.53 |
| 2024-09-20 | -28.28 |